Trade Summary

3 days ago, Lalwani Nikhil, serving as Pres, CEO at Ani Pharmaceuticals Inc (ANIP), sold 55,000 shares at $77.57 per share, for a total transaction value of $4,266,350.00. Following this transaction, Lalwani Nikhil now holds 349,889 shares of ANIP.

This sale represents a 14.00% decrease in Lalwani Nikhil's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 2 days after the trade was made.

Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.